iAnthus Capital (CSE:IAN)
- Ticker 2:OTC:ITHUF
- CEO:Hadley Ford
iAnthus Capital (CSE:IAN) Stock Price
iAnthus Capital (CSE:IAN) Company Overview
iAnthus (CNSX: IAN) was founded by experienced entrepreneurs, with backgrounds in operations, investment banking, corporate finance, law and health care, who each brought a unique set of skills and expertise to the table. A change in strategy in early 2018, led the company to move from passive investors, to executive owners of their investments. All hands on deck from there.
The company now operates across 11 U.S. States and owns 23 dispensaries, boasting the full gamut of vertically-integrated cannabis operations; from cultivation to processing and retailing. The company's investments are most notable in Massachusetts, New York and Florida, Nevada, Arizona and California which all exist in markets with large populations, strong growth characteristics and limited licenses.
iAnthus was the first multi-state operator in the U.S. to go public and raise money in Canada, and in February the company entered into a merger with MPX Bioceuticals Corp. The combination, valued at C$835 million, was at the time the largest public cannabis transaction in the U.S. The company also received a $50 million investment from Gotham Green Partners, considered one of the shrewdest in the industry.
The company also recently acquired 'CBD For Life' for $10.4 Million to gain access to CBD For Life's suite of CBD products, which are currently distributed to over 1,000 retail locations throughout 46 U.S. states.
- Address:Suite 414, 420 Lexington Avenue, New York, NY 10170, USA
iAnthus Capital (CSE:IAN) Financials
The latest update from the companyClick Here
Stay updated about
Signup to get updates.
Ford has an M.B.A. from Stanford University's Graduate School of Business and a B.S. in Business Admin from Boston University.
He is also a Co-Founder of Internet Gaming Entertainment U.S., where he served as Senior Vice President, as well as being General Counsel and a member of the Board of Directors.
He has also advised major academic research centres in Europe and the Middle East on the development of proton therapy projects, and has 15 years experience at the construction services firm, George B.H. Macomber Company, which includied 5 years serving as President.
He previously served as a partner and leader of cannabis investments at BG Partners Corp, and was also a formerly a investment banking director at CIBC and Dundee Capital Markets, where he worked on over 40 transactions worth over $5 billion.